Expert Opin Pharmacother. 2006 Dec;7(18):2599-603.

Partial agonism at nicotinic receptors with varenicline--a new approach to smoking cessation.

Source

School of Science, Faculty of Education, Health and Science, Charles Darwin University, Darwin, Northern Territory 0909, Australia. sheila.doggrell@cdu.edu.au

Comment on

PMID:: 17150012; [PubMed]

Publication Types

Comment

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review Varenicline: a first-line treatment option for smoking cessation. [Clin Ther. 2009]
Review Varenicline: a first-line treatment option for smoking cessation.
Garrison GD, Dugan SE. Clin Ther. 2009 Mar; 31(3):463-91.
Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist. [J Cardiovasc Nurs. 2006]
Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
Tonstad S. J Cardiovasc Nurs. 2006 Nov-Dec; 21(6):433-6.
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. [Neuropharmacology. 2007]
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, et al. Neuropharmacology. 2007 Mar; 52(3):985-94. Epub 2006 Dec 8.
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. [Clin Ther. 2007]
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
Tsai ST, Cho HJ, Cheng HS, Kim CH, Hsueh KC, Billing CB Jr, Williams KE. Clin Ther. 2007 Jun; 29(6):1027-39.
Review Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline? [Expert Opin Pharmacother. 2007]
Review Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Doggrell SA. Expert Opin Pharmacother. 2007 Dec; 8(17):2903-15.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Partial agonism at nicotinic receptors with varenicline--a new approach to smoki...
Partial agonism at nicotinic receptors with varenicline--a new approach to smoking cessation.
Expert Opin Pharmacother. 2006 Dec ;7(18):2599-603.

PubMed
Sex- and APOE isoform-dependent effects of radiation on cognitive function.
Sex- and APOE isoform-dependent effects of radiation on cognitive function.
Radiat Res. 2006 Dec ;166(6):883-91.

PubMed
The particle size of hepatitis C virus estimated by filtration through microporo...
The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre.
J Gen Virol. 1991 Aug ;72 ( Pt 8):2021-4.

PubMed
Getting the at risk patient back to work--a strategy.
Getting the at risk patient back to work--a strategy.
Aust Fam Physician. 2006 Dec ;35(12):952-6.

PubMed
Back injuries--getting injured workers back to work.
Back injuries--getting injured workers back to work.
Aust Fam Physician. 2006 Dec ;35(12):940-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Partial agonism at nicotinic receptors with varenicline--a new approach to smoking cessation.

Source

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information